Newsfeeds - Spark Newswire

1 minute read

Astria Therapeutics Commences Initial-Stage Skin Disorder Study, Sees Preliminary Data By Year-end

Today, 11:58 AM

Astria Therapeutics (NASDAQ: ATXS) announced initiation of a Phase 1a clinical trial of STAR-0215 in healthy subjects. STAR-0215 is designed to provide long-acting, effective attack prevention for hereditary angioedema (HAE), with dosing once every three months or longer.

ATXS

3 minute read

Recap Of Thursday’s Biotech Catalysts – End of The Day Summary

By Ragothaman Srinivasan

Today, 11:58 AM

Cyclerion Therapeutics (NASDAQ:CYCN) announced positive topline data from its clinical study of CY6463 for the treatment of Cognitive…

ACER

3 minute read

Daily Biotech Pulse: GSK’s Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion’s Schizophrenia Candidate

By Vandana Singh

Today, 11:58 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 11:58 AM

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million.

ATXS

4 minute read

62 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:58 AM

Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.

AFRM

1 minute read

Astria Therapeutics Q1 EPS $(1.18)

By Benzinga Newsdesk

Today, 11:58 AM

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(1.18) per share.

ATXS

2 minute read

(ATXS) – Analyzing Astria Therapeutics Inc. – Common Stock’s Short Interest

By Benzinga Insights

Today, 11:58 AM

Astria Therapeutics Inc. - Common Stock's (NASDAQ:ATXS) short percent of float has fallen 18.83% since its last report. The company recently reported that it has 150.40 thousand shares sold short, which is 1.25% of all regular shares that are available for trading.

ATXS